4//SEC Filing
Besch Doug 4
Accession 0001628280-25-058408
CIK 0001448431other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 10:07 AM ET
Size
8.9 KB
Accession
0001628280-25-058408
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Besch Doug
Chief Product Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-19+1,964→ 71,536 total - Tax Payment
Common Stock
2025-12-19$13.51/sh−581$7,849→ 70,955 total - Exercise/Conversion
Restricted Stock Units
2025-12-19−1,964→ 1,964 totalExp: 2026-12-19→ Common Stock (1,964 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
- [F3]The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001947731
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 10:07 AM ET
- Size
- 8.9 KB